Phase 3 study of pimodivir plus standard of care in hospitalized patients with influenza A

Phase 3, randomised, double-blind trial in Influenza A infection comparing Pimodivir plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Hospital recovery scale on Day 6. Started Mar 2019; status: completed.